Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 137.685 USD 0.96%
Market Cap: 8.2B USD
Have any thoughts about
Ascendis Pharma A/S?
Write Note

Balance Sheet

Balance Sheet Decomposition
Ascendis Pharma A/S

Current Assets 973.7m
Cash & Short-Term Investments 625.5m
Receivables 50.4m
Other Current Assets 297.9m
Non-Current Assets 120m
Long-Term Investments 16.2m
PP&E 97.5m
Intangibles 4.1m
Other Non-Current Assets 2.2m
Current Liabilities 838.5m
Accounts Payable 75.3m
Short-Term Debt 422.1m
Other Current Liabilities 341.1m
Non-Current Liabilities 352.6m
Long-Term Debt 338.9m
Other Non-Current Liabilities 13.7m

Balance Sheet
Ascendis Pharma A/S

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
50
120
180
195
278
592
585
446
445
392
Cash Equivalents
50
120
180
195
278
592
585
446
445
392
Short-Term Investments
0
0
0
0
0
0
134
236
291
7
Total Receivables
2
2
2
2
3
5
7
23
26
56
Accounts Receivables
1
1
0
0
0
1
0
2
12
36
Other Receivables
1
1
1
2
3
5
7
21
14
20
Inventory
0
0
0
0
0
0
0
75
131
209
Other Current Assets
1
4
2
7
12
13
14
25
32
39
Total Current Assets
53
126
184
205
293
611
740
806
924
703
PP&E Net
2
2
2
3
4
45
108
126
129
111
PP&E Gross
2
2
2
3
4
45
108
126
129
111
Accumulated Depreciation
3
3
4
4
5
11
20
34
47
72
Intangible Assets
0
0
0
0
0
0
2
2
1
1
Goodwill
4
4
4
4
4
4
4
4
4
3
Note Receivable
0
0
0
0
0
0
1
2
2
2
Long-Term Investments
0
0
0
0
17
16
125
146
30
6
Other Long-Term Assets
0
0
0
0
1
2
0
0
0
0
Other Assets
4
4
4
4
4
4
4
4
4
3
Total Assets
59
N/A
132
+125%
190
+44%
211
+11%
319
+51%
677
+112%
980
+45%
1 085
+11%
1 090
+0%
826
-24%
Liabilities
Accounts Payable
5
8
13
24
20
28
22
59
101
95
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
6
7
7
25
25
Other Current Liabilities
8
3
0
0
19
14
24
34
45
77
Total Current Liabilities
13
11
14
24
39
48
53
100
171
197
Long-Term Debt
0
0
0
0
0
31
85
98
483
619
Deferred Income Tax
0
0
0
0
0
0
0
0
0
6
Other Liabilities
0
0
0
0
0
1
3
3
172
149
Total Liabilities
13
N/A
11
-12%
14
+18%
24
+76%
39
+63%
80
+105%
141
+77%
201
+43%
826
+311%
971
+18%
Equity
Common Stock
2
3
4
5
6
1 129
1 736
2 115
2 121
2 131
Retained Earnings
44
117
172
0
0
531
897
1 214
1 861
2 277
Treasury Stock
0
0
0
0
0
0
0
22
0
0
Other Equity
0
0
0
182
274
0
0
4
4
1
Total Equity
46
N/A
120
+163%
177
+47%
187
+6%
280
+50%
597
+113%
839
+40%
884
+5%
263
-70%
146
N/A
Total Liabilities & Equity
59
N/A
132
+125%
190
+44%
211
+11%
319
+51%
677
+112%
980
+45%
1 085
+11%
1 090
+0%
826
-24%
Shares Outstanding
Common Shares Outstanding
23
25
32
37
42
48
54
57
57
58

See Also

Discover More